About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Princess Margaret Cancer Centre
›
Division of Medical Oncology and Hematology
›
Top Articles
Division of Medical Oncology and Hematology
Princess Margaret Cancer Centre
3.6K
Articles
59.9K
Citations
3.2
avg. Impact Factor
96
h-index
Most Cited Articles of Division of Medical Oncology and Hematology in 2015
Title
Journal
Year
Citations
Expanding global access to radiotherapy
Lancet Oncology, The
2015
457
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Nature Genetics
2015
306
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
Lancet Oncology, The
2015
229
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Annals of Oncology
2015
220
Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience
European Urology
2015
178
A systematic review of factors influencing older adults' decision to accept or decline cancer treatment
Cancer Treatment Reviews
2015
152
A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors
Annals of Oncology
2015
139
The clinical significance of hypoxia in human cancers
Seminars in Nuclear Medicine
2015
133
Pembrolizumab
2015
131
Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer
Annals of Oncology
2015
129
Survivorship and Quality of Life in Head and Neck Cancer
Journal of Clinical Oncology
2015
129
Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis
European Urology
2015
129
Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status
Cancer
2015
109
525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028
European Journal of Cancer
2015
99
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer
Annals of Oncology
2015
97
APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation
Proceedings of the National Academy of Sciences of the United States of America
2015
95
International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma
JAMA Ophthalmology
2015
94
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials
Annals of Oncology
2015
92
Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance
Cancer Medicine
2015
87
A systematic review of quality of life in head and neck cancer treated with surgery with or without adjuvant treatment
Oral Oncology
2015
84
The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer
Oncotarget
2015
84
Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle
Journal of Controlled Release
2015
83
Aprepitant and fosaprepitant: a 10-year review of efficacy and safety
Oncologist
2015
79
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
Journal of Enzyme Inhibition and Medicinal Chemistry
2015
79
Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study
Breast Cancer Research
2015
76
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.